Infliximab for induction and maintenance therapy for ulcerative colitis.

Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF

Open source

DOI: 10.1056/nejmoa050516
Published: 2005 Dec 8
Container: The New England journal of medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa050516,
  title = {Infliximab for induction and maintenance therapy for ulcerative colitis.},
  author = {Rutgeerts P and Sandborn WJ and Feagan BG and Reinisch W and Olson A and Johanns J and Travers S and Rachmilewitz D and Hanauer SB and Lichtenstein GR and de Villiers WJ and Present D and Sands BE and Colombel JF},
  year = {2005},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa050516},
  url = {https://doi.org/10.1056/nejmoa050516}
}

RIS

TY  - JOUR
TI  - Infliximab for induction and maintenance therapy for ulcerative colitis.
AU  - Rutgeerts P
AU  - Sandborn WJ
AU  - Feagan BG
AU  - Reinisch W
AU  - Olson A
AU  - Johanns J
AU  - Travers S
AU  - Rachmilewitz D
AU  - Hanauer SB
AU  - Lichtenstein GR
AU  - de Villiers WJ
AU  - Present D
AU  - Sands BE
AU  - Colombel JF
PY  - 2005
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa050516
UR  - https://doi.org/10.1056/nejmoa050516
ER  -

APA

P, R., WJ, S., BG, F., W, R., A, O., J, J., S, T., D, R., SB, H., GR, L., WJ, D. V., D, P., BE, S., & JF, C. (2005). Infliximab for induction and maintenance therapy for ulcerative colitis.. The New England journal of medicine. https://doi.org/10.1056/nejmoa050516

Source records

pubmed · retrieved 2026-09-25T08:27:08.295Z